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CURRENTOPINION A review of neurocognitive functioning and risk
for psychopathology in sex chromosome trisomy
(47,XXY, 47,XXX, 47, XYY)
Sophie van Rijna,b
Purpose of review
About one in 650–1000 children is born with an extra X or Y chromosome, referred to as sex
chromosome trisomies (SCTs). Studying SCTs may uncover unique insights in neurodevelopmental pathways
underlying the risk for neurobehavioral problems and psychopathology. There is also a clinical need for
more knowledge about the phenotype of SCT with the recent introduction of noninvasive prenatal
screening.
Recent findings
The reviewed studies illustrate an increased vulnerability for psychopathology such as (symptoms of) autism
spectrum disorder, attention-deficit/hyperactivity disorder, anxiety, depression and, to a lesser degree,
psychotic disorders. Although traditionally the primary focus has been on language and learning problems,
recent research suggests that impairments in executive functioning, social cognition and emotion regulation
may also be key factors underlying the risk for neurobehavioral problems.
Summary
The research field of SCT is in need of a more longitudinal perspective to identify early markers of ‘at risk’
development, and to assess the effectiveness of early interventions. Neurocognitive markers that signal
compromised neurodevelopment may prove to be helpful in this. Variability in the SCT phenotype provides
a unique opportunity to identify not only genetic but also environmental factors that shape
neurodevelopmental outcome, calling for studies focused on understanding individual differences.
Keywords
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INTRODUCTION
About one in 650–1000 children is born with an extra
X or Y chromosome, resulting in the 47,XXY,
47,XXX or 47,XYY chromosomal pattern. The most
common cause is nondisjunction of the X or Y chro-
mosome during early cell division, most often during
meiosis. Knowledge about the neurocognitive and
behavioralphenotypes remains rather limited,which
is somewhat surprising considering the dispropor-
tionate amount of genes on the X chromosomes that
have been linked to brain functioning [1].
However, in the last two decades, sex chromo-
some variations have received increased attention,
in part driven by an increasing awareness that study-
ing gene–brain–behavior pathways in these genetic
conditions may uncover new insights in mecha-
nisms of developmental risk that may lead to
psychopathology. It has been argued that this
‘behavioral neurogenetics approach’ [2] may pro-
vide a powerful tool that can complement the study
of behaviorally defined populations. As sex chromo-
some trisomies (SCTs) can already be identified as
early as prenatally, this offers the opportunity to
prospectively study early neurodevelopmental
markers of individual differences in outcome in
terms of neurobehavioral symptoms and risk for
psychopathology. There is also an increasing clini-
cal need for knowledge about SCT. The number of
children prenatally diagnosed with SCT is expected
to increase with availability of the noninvasive pre-
natal screening test [3], which calls for more knowl-
edge about the phenotype of SCT to be able to
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monitor child development, and provide clinical
care and early support or intervention if needed.
This need for knowledge may be most pressing for
the neurobehavioral domain: so far, the majority of
research studies (about 75%) have focused on the
somatic/medical phenotype, with only 25% of the
studies focusing on the neurobehavioral phenotype
[4]. In addition to characterizing the variety and sever-
ityofbehavioralproblemsthatmaybeseeninSCT, it is
also of great importance to have a better understand-
ing of the mechanisms underlying the behavioral
phenotype. Similar behavioral problems may arise
from different underlying informationprocessingdys-
functions in the brain. Knowledge about these cogni-
tive dysfunctions that are core to behavioral problems
in SCT is crucial for disentangling etiological path-
ways, and is also essential for identifying the nature of
developmental vulnerability, as well as the identifica-
tion of specific targets for intervention, enabling more
tailored mental healthcare.
Here, a compact review is provided of risk for
psychopathology and neurocognitive vulnerabil-
ities that may underlie this increased risk in indi-
viduals with SCT. Recent developments in this field




A systematic review has established a worldwide
prevalence rate of autism spectrum disorder (ASD)
of0.6% inthe general population [5]. Levelsof autism
symptoms and risk for ASD have shown to be signifi-
cantly higher in SCT as compared to the general
population. To illustrate, on average, 25% children
with XXY (ranging from 12 to 47%) have autism
symptoms in the mild/moderate-to-severe range
[6–9]. When considering diagnostic classification
of ASD, on average 18% of the children meet full
ASD criteria, with a range of 10–27% [7,10,11]. When
looking at the history of clinical diagnoses based on
screening of medical files or parental report, this
percentage is somewhat lower at 7% (ranging from
5 to 11%) [6,9,12]. Increased levels of ASD symptoms
have also been found in adults with XXY, with 6.5%
scoring above clinical cutoff [13]. This fits with a
screening of hospital discharges in 860 adults with
XXY, showing that ASD was diagnosed 6.2 times
more often as compared to men with XY [14].
Also, for individuals with XXX, significantly
increased rates of ASD diagnoses or clinically signif-
icant ASD symptoms have been observed, with an
average rate of 15% of the children (ranging from
10.8 to 20%) [7,15].
In individuals with XYY, a clinical diagnostic
classification of ASD has been found in on average
30% of the children (ranging from 19 to 43%)
[9,10,12,16,17]. Studies using dimensional measures
have shown that 35% of the boys have ASD symp-
toms in the mild–moderate range, and another 50%
in the severe range [9].
ATTENTION DEFICIT HYPERACTIVITY
DISORDER SYMPTOMS
A meta-analysis of worldwide attention deficit hyper-
activity disorder (ADHD) prevalence in children
found an overall estimate of 7.2% [18]. As compared
to the general population, significantly higher levels
of ADHD symptoms as well as increased risk for
ADHD have been reported for SCT. Using dimen-
sional measures, clinical levels of ADHD symptoms
have been found in on average 35% of the children
with XXY (with a range of 27–42%) [9,19,20], with
inattentive symptoms more predominant than
hyperactive/impulsive symptoms [20]. When consid-
ering full diagnostic classification of ADHD (either
direct assessment or clinical history), on average 43%
of the children and adolescents (with a range of 34–
63%) meet diagnostic and statistical manual of men-
tal disorders (DSM) criteria for ADHD [6,9,11,21]. In
adults with XXY, ADHD was diagnosed 5.6 times
more often according to a screening of hospital dis-
charges in860adultswithXXY ascompared to86 000
men with XY [14].
A review on XXX has reported an estimated 25–
35% of the individuals with XXX having ADHD
KEY POINTS
 A subgroup of individuals with SCT is at increased risk
for neurobehavioral problems and psychopathology.
 Neurocognitive factors that may drive this increased
risk include impairments in language, executive
functioning, social cognition and emotion regulation.
 Insight in these underlying cognitive mechanisms
provides opportunities for improving diagnostic
screening, and subsequent close monitoring of
vulnerable children with SCT, in order to positively
influence developmental outcome through early support
and tailored intervention.
 As SCT can be identified already prenatally, studying
SCT can help in identifying early markers of ‘at-risk’
developmental pathways in childhood.
 Variability in the phenotype in SCT may help in
identifying risk and protective factors that shape
developmental outcome of children, focusing not only
on genetic factors but also on environmental factors.
Neurodevelopmental disorders
80 www.co-psychiatry.com Volume 32  Number 2  March 2019
 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
[19,22]. Somewhat higher rates have also been
reported with on average 49% (ranging from 46.7
to 52%) having attention symptoms in the clinical
range [20,23], which is in line with a recent study
reporting 48.9% of the girls with XXX having a
diagnosis of ADHD [15].
For XYY, dimensional measures have shown
that on average 69% of the XYY boys (ranging from
62 to 76%) had clinical levels of ADHD symptoms
[9,20]. An average of 36% of boys with XYY (ranging
from 11 to 52%) met full diagnostic criteria for
ADHD, either based on clinical evaluation or history
of psychiatric diagnoses [9,16,17].
PSYCHOTIC SYMPTOMS
On the basis of meta-analysis, the median global
prevalence of psychotic disorders in the general
population has been estimated at 0.46% [24]. A
screening of hospital discharges in 860 adults with
XXY revealed that psychotic disorders (schizophre-
nia or bipolar disorder) were diagnosed 7.4 times
more often as compared to men with the typical XY
pattern [14]. Clinical assessment studies have shown
that 12% of the children with XXY [11] and 6.5% of
the adults with XXY [25] meet DSM criteria for a
psychotic disorder. In those with XXX, bipolar or
psychotic disorders have been observed in 13.3%
[15]. In individuals with XYY, psychiatric screening
revealed a rate of 8% for bipolar disorder [17].
When considering dimensional measures, sig-
nificantly higher rates of thought problems in SCT
have been found in comparison to the general pop-
ulation: 37.8% of the children with XXY or XXY [19]
and 30% of the individuals with XXX [23].
ANXIETY/DEPRESSION SYMPTOMS
Meta-analysis has shown global prevalence rates of
7.3% for anxiety disorders [26] and 12.9% for
depression [27] in the general population. Data
suggest that rates may be higher in SCT, although
direct comparisons with control groups are lacking,
except for two more recent studies using dimen-
sional measures in SCT groups versus control
groups, which showed mixed results [19,23]. In
individuals with XXY, the average reported rate of
depressive disorders is 26.9% (ranging from 12 to
68%) [6,11,25,28,29]. Clinically significant anxiety
symptoms have been observed in on average 20.5%
of the children with XXY (ranging from 14 to 27%)
[6,19]. The reported rates of depression in XXX
range from 17.8 [15] to 54% [28]. Anxiety disorders
have been found in 19.5% [15] and clinical levels of
anxiety-depression symptoms in 27–30% of the
individuals with XXX [19,23]. As for XYY, a reported
13% had a depressive disorder and 26% had an
anxiety disorder [17].
NEUROCOGNITIVE VULNERABILITY
Although IQ is typically at the borderline or lower
end of the normal range [30], and intellectual disabil-
ity is not common, the majority of children with SCT
have specific cognitive impairments to some degree.
Although the majority of studies have traditionally
primarily focused on describing academic achieve-
ment and global intellectual levels, in recent years
more and more studies have relied on comprehensive
performance-based assessment of multiple and spe-
cific cognitive domains, as outlined below.
LANGUAGE
One of the best described and most recognized
domains of cognitive vulnerability is language dys-
function. To illustrate, about 70–80% of children
with 47,XXY have language difficulties that are typi-
cally present already from a young age [31]. This
finding has been quite robust, being shown innumer-
ous and unbiased samples [30,31]. Compromised
language development is not only characteristic for
boys with XXY, but also for boys with XYY and girls
with XXX, although the degree of impairment may
vary somewhat depending on the karyotype [32].
Difficulties include both receptive and expressive
language skills (with the latter typically somewhat
more affected), as well as difficulties in communica-
tion and language pragmatics [12,33]. Although the
majority of studies have focused on school-aged chil-
dren, more recent neuropsychological studies (of
children with XXY and XXX) have started to investi-
gate language development in children as young as
18–24 months, describing smaller vocabulary size




With regard to the association between lan-
guage dysfunction and psychopathology, two stud-
ies have shown that more compromised language
functioning is directly associated with higher levels
of autism symptoms in children, adolescents and
adults with XXY [8,36].
EXECUTIVE FUNCTIONING
Executive functions are considered essential for flex-
ible adaptive functioning in complex situations that
have a high load of information, for inhibition of
irrelevant actions and thoughts, for dealing with
changing environmental demands and for organi-
zation of actions and thoughts in a goal-directed
way. Although some of the early studies on
A review of neurocognitive functioning van Rijn
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executive function emphasized primarily working
memory impairments in SCT [37], there is now
increasing evidence for significant difficulties (as
compared to the general population) in a range of
executive function functions including inhibition,
mental flexibility, strategic planning, fluency, work-
ing memory and sustained attention regulation,
with medium-to-large effect sizes [19,21,38,39].
Although the majority of studies have focused on
XXY and XXX, executive function problems have
also been found in boys with XYY, with somewhat
more compromised scores as compared to XXY [32].
In a study including both boys with XXY and girls
with XXX, rates of 16–37% of the children with
clinically impaired executive dysfunction were
found [19]. A very recent international investigation
of boys with XXY showed rates of 23–57% of the
children having executive function dysfunctions
within the clinically impaired range [40
&
]. Vulnera-
bility in executive function also seems to translate to
daily life difficulties in executive function as
observed by parents [19,41]. Executive function
problems may show variability across age [41,42],
are observed in both boys with XXY and girls with
XXX [19,41] and may be more pronounced in the
context of early life stressors [43].
In terms of the role of executive function diffi-
culties in behavioral symptoms and risk for psycho-
pathology in SCT, there is evidence showing that
compromised executive functioning is significantly
associated with increased externalizing behavior
problems [19], increased social difficulties and
ASD symptoms [39,44], increased psychotic symp-
toms such as disorganized thought [45] and
increased symptoms of ADHD [21].
SOCIAL COGNITION AND EMOTION
Social cognition refers to the ability to perceive,
understand and express social signals, which is cru-
cial for successful social adaptation. Emotions, if
well regulated, also have an important role in social
functioning by facilitating behaviors that are adap-
tive to the social environment [33]. In the last
decade, several studies in individuals with XXY or
XXX have revealed significant impairments in these
areas as compared to the general population. These
include difficulties in reading social signals from
social gaze direction [46] or tone of voice [47] and
difficulties in recognizing emotional expressions
from faces [48,49
&
,50], which may be more pro-
nounced in the context of early life stressors [43].
A reported 16–43% of the children with XXY [40
&
]
and 33% of the adults with XXY [49
&
] have facial
affect recognition problems in the clinically
impaired range. In addition to understanding facial
expressions, research suggests that significantly
more children with XXY or XXX have difficulties
with theory of mind [48], referring to the attribution
of mental states, intentions and emotions to others.
A very recent study suggests that children and adults
with XXY may have disproportionate difficulties
when ‘social load’ of information increases, reveal-
ing difficulties in the higher order labeling and
interpretation of social cues [49
&
].
The processing of facial emotions has been stud-
ied in more detail using eyetracking. One of these
studies showed that adults with XXY looked less to
the eye region of faces and did not show the typical
tendency to first fixate on the eyes when presented
with a face [51]. Shorter looking times were associ-
ated with poorer social functioning. Another eye-
tracking study in adults with XXY showed decreased
attention to the eyes of characters displaying emo-
tions, but increased affective arousal in response to
these emotions [52]. This hyperarousal fits with
studies showing increase social anxiety in men with
XXY [13] and children with XXY or XXX [7], as well
as increased subjective emotional arousal in
response to emotion-inducing events, and increased
influence of emotions during strategic, goal-
directed tasks in adults with XXY [50]. Such
increased affective arousal levels may negatively
affect social interactions, especially as difficulties
in recognizing and labeling of own emotions have
been found in adults with XXY [50], which likely
hampers the implementation of emotion regulation
strategies. Indeed, more problems in the regulation
of emotions have been reported for children and
adolescents with XXY or XXX [41].
CONCLUSION
The reviewed studies illustrate an increased risk for
social, emotional and behavioral problems in individ-
uals with SCT. Although traditionally the primary
focus has been on language and learning problems,
more recent research suggests that impairments in
executive functioning, social cognition and emotion
regulation may also be key factors underlying the risk
for behavioral problems and psychopathology.
Insight in these underlying cognitive mechanisms
provides opportunities for improving diagnostic
assessment, and subsequent close monitoring of vul-
nerable children with SCT, in order to positively influ-
ence developmental outcome through early support
and tailored intervention. Early implementation of
preventive interventions, delivered during key win-
dows of opportunity when neurodevelopment is most
sensitive for environmental influences, has the poten-
tial to optimize quality of life and reduce risk for
mental health problems later in life [53].
Neurodevelopmental disorders
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Ascertainment and recruitment biases are
always important factors in SCT research, and con-
tribute to the variance in the described vulnerabil-
ities and lack of representation for the full
population. In interpreting study findings, it is
important to distinguish cohorts recruited for
research purposes versus those that represent clini-
cal samples. Also, cohorts identified through post-
natal identification likely overestimate severity of
the SCT phenotype (because of preselection of more
severe cases), whereas cohorts identified based on
prenatal screening may underestimate severity of
the phenotype (because of higher socioeconomic
status and implementation of early support and
intervention). Increased awareness of these biases
and increasing attempts to investigate the impact of
these biases in studies with mixed prenatal/postna-
tal samples are helpful in determining the full range
of outcomes in SCT.
The research field of SCT is in need of a more
longitudinal perspective to study the described neuro-
cognitive and behavioral aspects of the phenotype of
SCT already from an earlyageonward. SCT canalready
be diagnosed prenatally, providing the responsibility
and at the same time unique opportunity to identify
early markers of ‘at risk’ development. Neurocognitive
assessments that signal compromised neurodevelop-
ment may prove to be helpful in this.
StudyingSCTmay also help in generating specific
genetic hypotheses. Although few studies so far have
attempted to link specific genes on the X or Y chro-
mosomes to the neurobehavioral phenotype, recent
studies have yielded very promising results [54].
Nonetheless, it is important to acknowledge that it
is not all about the genes, and that is only in interac-
tion with the environment that the phenotype is
shaped, contributing to variability in outcome in
SCT. This calls for a more integrated perspective
considering developmental vulnerabilities in chil-
dren with this genetic syndrome in the context of
environmental factors, which may also help in iden-
tifying protective factors that could be targeted to
reduce developmental risk as much as possible.
Focusing on subgroups and individual differences
rather than relying on group averages may also help
uncover key mechanisms that contribute to risk for
specific and different types of psychopathology.
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